With $75.1 million in cash and minimal competition, aTyr Pharma is well-positioned financially, making it a compelling ...
Atlanta Black Star on MSN3h
‘You Think I’m Playing?!’: Bernie Mac Reveals In Resurfaced Clip His Wife Turned Him Into a Nervous Wreck After Putting Her Foot DownFans are still heralding Bernie Mac as one of the greatest acts in comedic history as they continue to laugh at one of his most memorable jokes. The late ...
Q4 2024 Earnings Call Transcript March 13, 2025 aTyr Pharma, Inc. beats earnings expectations. Reported EPS is $-0.18, expectations were $-0.23. Operator: Good afternoon, ladies and gentlemen, and ...
Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025.
No safety concerns identified by independent data and safety monitoring board (DSMB), which recommends continuation of study ...
Cardiac sarcoidosis (CS) was a complication in about 10% of pulmonary sarcoidosis (PS) cases, investigators reported in Respiratory Medicine. The retrospective study assessed the prevalence, incidence ...
The following is a summary of "Respiratory abnormalities in sarcoidosis: physiopathology and early diagnosis using ...
Topline data from Phase 3 EFZO-FIT study of efzofitimod in pulmonary sarcoidosis expected in the third quarter of 2025. Fourth positive DSMB review for efzofitimod in Phase 3 EFZO-FIT study reinforces ...
Peer-reviewed publication validates efzofitimod’s unique anti-inflammatory mechanism of action on macrophages through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback